Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,750 | 2 | 94.6% |
| Food and Beverage | $156.04 | 5 | 5.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Organon LLC | $2,750 | 2 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $156.04 | 5 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $2,779 | 4 | Organon LLC ($2,750) |
| 2019 | $111.86 | 2 | Merck Sharp & Dohme Corporation ($111.86) |
| 2017 | $15.21 | 1 | Merck Sharp & Dohme Corporation ($15.21) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/12/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 06/14/2021 | Organon LLC | Nexplanon (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: WOMENS HEALTH | ||||||
| 05/04/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: WOMENS HEALTH | ||||||
| 04/27/2021 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: WOMENS HEALTH | ||||||
| 06/27/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $92.12 | General |
| Category: WOMENS HEALTH | ||||||
| 06/27/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: WOMENS HEALTH | ||||||
| 06/27/2017 | Merck Sharp & Dohme Corporation | NUVARING (Drug), NEXPLANON | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 226 | 449 | $76,850 | $25,553 |
| 2022 | 7 | 210 | 387 | $70,787 | $20,189 |
| 2021 | 2 | 99 | 111 | $26,973 | $6,762 |
| 2020 | 4 | 93 | 128 | $35,198 | $6,784 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 138 | $29,876 | $8,056 | 27.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 44 | 44 | $9,739 | $5,135 | 52.7% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 25 | 149 | $17,031 | $4,846 | 28.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 54 | $7,804 | $3,170 | 40.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 21 | $4,509 | $1,858 | 41.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 12 | 16 | $3,760 | $1,366 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 27 | $4,131 | $1,120 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 142 | $32,801 | $8,501 | 25.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 25 | 132 | $15,852 | $5,137 | 32.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 42 | $6,594 | $2,260 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 36 | $5,598 | $1,515 | 27.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,322 | $1,124 | 33.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 12 | 13 | $3,172 | $1,026 | 32.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $3,448 | $626.61 | 18.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 59 | $16,726 | $4,497 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 34 | $6,071 | $1,489 | 24.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 18 | $4,176 | $775.20 | 18.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 38 | $8,892 | $2,237 | 25.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 27 | $9,288 | $1,930 | 20.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 29 | 29 | $6,728 | $1,076 | 16.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 21 | $4,872 | $977.40 | 20.1% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Facility | 2020 | 12 | 13 | $5,418 | $563.53 | 10.4% |
About Dr. Neelima Kale, MD
Dr. Neelima Kale, MD is a Family Medicine healthcare provider based in Deer Park, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487693818.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Neelima Kale, MD has received a total of $2,906 in payments from pharmaceutical and medical device companies, with $2,779 received in 2021. These payments were reported across 7 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($2,750).
As a Medicare-enrolled provider, Kale has provided services to 628 Medicare beneficiaries, totaling 1,075 services with total Medicare billing of $59,287. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location Deer Park, TX
- Active Since 06/04/2006
- Last Updated 05/20/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487693818
Products in Payments
- Nexplanon (Drug) $2,750
- NEXPLANON (Drug) $140.83
- NUVARING (Drug) $15.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Deer Park
Behrouz Farahmandpour, D.o, D.O
Family Medicine — Payments: $30,635
Francine Dimaria, D.o, D.O
Family Medicine — Payments: $9,445
Dr. Edwardo Yambo, Md, MD
Family Medicine — Payments: $7,067
Dr. Basil Griffin, M.d, M.D
Family Medicine — Payments: $5,527
Joseph Dic, D.o, D.O
Family Medicine — Payments: $4,468
Dr. Marc Lewandoski, Do, DO
Family Medicine — Payments: $4,031